Science-Backed Benefits

Red Light Therapy & Hormones

How photobiomodulation interacts with cortisol, melatonin, and the stress-sleep cycle — and what is well-evidenced vs. what remains preliminary

Important: Red light therapy devices are positioned for general wellness use only. This article discusses the research on RLT and hormonal physiology. It does not constitute medical advice. If you have a diagnosed endocrine condition, consult your doctor before beginning any light therapy protocol.

The relationship between light and hormonal regulation is well established in chronobiology — the science of biological timing. What is less well understood by most wellness consumers is how therapeutic red and near-infrared light specifically — as distinct from broad daylight — influences hormonal signalling through the cellular mechanisms of photobiomodulation.

This article covers what the peer-reviewed literature actually shows about red light therapy and three hormonal systems where the evidence is most developed: cortisol and the stress response, melatonin and the sleep-wake cycle, and the hypothalamic-pituitary-adrenal (HPA) axis. We also cover what remains preliminary — thyroid function and sex hormones — and why those areas require more caution in how they are discussed.

Why Light Affects Hormonal Physiology: The Biological Foundation

The connection between light and hormonal regulation operates through two distinct pathways, and understanding which one applies to red light therapy is critical for making sense of the research.

Pathway 1: circadian phototransduction via the eye

The primary way light influences hormone levels is through the retinohypothalamic tract — a neural pathway connecting specialised photoreceptors in the retina (intrinsically photosensitive retinal ganglion cells, or ipRGCs) to the suprachiasmatic nucleus (SCN) in the hypothalamus. The SCN is the brain’s master clock, which synchronises the circadian timing of cortisol release, melatonin production, body temperature regulation, and dozens of other physiological rhythms.

Importantly, the ipRGCs that drive this pathway are most sensitive to short-wavelength blue light (~480 nm) and relatively insensitive to long-wavelength red light. This is why blue light in the evening suppresses melatonin and red light does not — the biological clock simply does not register red wavelengths as a strong zeitgeber (time cue).

Pathway 2: cellular photobiomodulation via skin

The second pathway is the one photobiomodulation operates through: direct photon absorption by cytochrome c oxidase (CCO) in tissue mitochondria. When red and near-infrared photons penetrate the skin, they activate CCO, increase ATP synthesis, displace inhibitory nitric oxide, and trigger downstream signalling cascades including NF-kB activation and nitric oxide vasodilation.

Hormone-producing cells — in the adrenal cortex, the pineal gland, the thyroid, and the gonads — contain mitochondria like all other cells. If those mitochondria are operating under chronic NO inhibition or oxidative stress (both common in aging and chronic stress states), their ATP output is reduced. Red light therapy may restore mitochondrial function in these glands, supporting the energy-dependent processes of hormone synthesis. This is the theoretical basis for the hormone-related effects of PBM, and it is mechanistically plausible — but the human clinical evidence is considerably less developed than for skin, muscle, or wound healing applications.

Key distinction: most of the strong evidence for RLT and circadian hormones (cortisol, melatonin) operates through the circadian pathway — i.e., the timing and spectral composition of light exposure, not the photobiomodulation mechanism. The direct cellular stimulation of endocrine glands is a more speculative pathway that requires larger human trials.

Cortisol and the Stress Response: What the Evidence Shows

Cortisol is a glucocorticoid hormone produced by the adrenal cortex. It follows a diurnal rhythm: levels peak within 30–45 minutes of waking (the cortisol awakening response, or CAR) and decline through the day, reaching their lowest point in the early hours of sleep. This rhythm is central to energy regulation, immune function, and metabolic health — disruption is associated with fatigue, anxiety, impaired immunity, and weight gain.

How light timing affects cortisol

A systematic review of 12 randomised controlled trials (337 participants) examined the effect of light exposure on the cortisol awakening response. The key finding: bright light with a higher blue/green spectral component in the morning produces a larger CAR than long-wavelength red light. Red light in the morning produces a gentler, more gradual cortisol rise — which has a different but arguably beneficial profile for people who experience excessive morning anxiety or stress-driven cortisol spikes.

The practical implication is nuanced. Red light therapy in the morning will not produce the same circadian-entraining effect as bright blue-white morning light — it does not strongly signal “wake up” to the SCN. However, for individuals who are prone to morning anxiety, adrenal dysregulation, or who experience harsh cortisol spikes, a morning RLT session may support a smoother, lower-amplitude cortisol curve rather than an exaggerated peak. This is wellness support, not endocrine treatment.

The HPA axis and chronic stress

The hypothalamic-pituitary-adrenal (HPA) axis is the primary physiological stress response system. Chronic psychological or physical stress leads to sustained HPA activation, elevated baseline cortisol, and eventual dysregulation — the pattern associated with burnout, chronic fatigue, and adrenal exhaustion.

The cellular mechanism by which red light therapy might support HPA axis regulation is through mitochondrial function in the adrenal cortex itself. Cortisol synthesis (steroidogenesis) is an energy-intensive process that depends heavily on mitochondrial ATP and cholesterol metabolism via the StAR protein and the CYP11A1 enzyme — both mitochondrial processes. Under chronic stress, mitochondrial dysfunction in the adrenal cells may impair the normal feedback mechanisms that regulate cortisol output. The ATP-restoring effect of PBM is theoretically beneficial here, but direct human evidence in this specific context is limited.

Honest summary of cortisol evidence:Well-evidenced: Red light does not produce the same morning cortisol spike as blue/white light — useful for those managing morning anxiety or cortisol sensitivity.Theoretically plausible but not yet clinically confirmed: Direct mitochondrial support of adrenal steroidogenesis via PBM. No large-scale human RCTs specifically on cortisol dysregulation yet.

Melatonin and Sleep: The Most Well-Understood Hormonal Effect

The relationship between red light and melatonin is the most clearly evidenced of all the hormone-related effects of PBM. It operates primarily through the absence of suppression — a different mechanism from most wellness interventions, which typically work by adding something.

Why red light does not suppress melatonin

Melatonin is produced by the pineal gland and is regulated by SCN input from the ipRGC retinal pathway described earlier. Because the ipRGCs are most sensitive to ~480 nm blue light, red wavelengths (630–850 nm) do not meaningfully activate this suppression pathway. Evening exposure to red light — from an RLT panel, from red-spectrum bulbs, or from a red-spectrum screen filter — does not delay melatonin onset the way blue-enriched light does.

This makes red light a practical lighting choice for the 1–2 hours before sleep — it provides ambient light for activity without the circadian disruption caused by blue-enriched LEDs or screens. The value is not that it raises melatonin — the evidence for direct melatonin-boosting effects of RLT is limited — but that it does not lower it when used appropriately in the evening.

The pineal gland and photobiomodulation

A small number of studies have explored the possibility that PBM applied to the skull or transcranially could directly influence the pineal gland — improving mitochondrial function in pineal cells and potentially supporting melatonin synthesis. The pineal gland is located deep within the brain; transcranial delivery of therapeutic near-infrared light (810 nm, which penetrates neural tissue) is technically feasible and is established for other neurological applications.

However, direct pineal stimulation via PBM remains a theoretical pathway. Small trials have suggested improved sleep quality in subjects using evening red light, but it is not possible from these studies to separate the contribution of melatonin-suppression avoidance (well-established) from any direct photobiomodulation effect on the pineal gland (speculative). The honest position is that the melatonin-sparing effect of red evening light is the reliable mechanism; direct pineal stimulation requires more investigation.

Practical implications for sleep

The sleep-relevant guidance that follows from the evidence is practical and accessible:

  • Evening light environment: Use red-spectrum lighting in the final 1–2 hours before sleep to avoid melatonin suppression. An RLT panel used for a skin or recovery session in the evening is compatible with this — it provides therapeutic benefit without circadian disruption.
  • Screen time: No RLT panel replaces the importance of reducing blue-screen exposure in the evening. The two strategies are complementary, not substitutes.
  • Timing: A 10–15 minute RLT session 60–90 minutes before sleep is consistent with the evidence on light and circadian timing. The absence of blue wavelengths means no melatonin suppression; the thermal relaxation from NIR exposure may support parasympathetic nervous system dominance.
Honest summary of melatonin evidence:Well-evidenced: Red light in the evening does not suppress melatonin — unlike blue-enriched light. This is the most practical and reliable hormonal effect of RLT for general use.Plausible but preliminary: Direct photobiomodulation of the pineal gland supporting melatonin synthesis. Requires larger, better-controlled trials.

Thyroid Function: Promising Early Data, Not Yet Clinical Guidance

The thyroid gland regulates metabolic rate through the hormones T3 (triiodothyronine) and T4 (thyroxine). Thyroid dysfunction is one of the most common endocrine disorders, particularly hypothyroidism and the autoimmune condition Hashimoto’s thyroiditis.

A small number of pilot studies have explored whether localised RLT applied over the thyroid gland can influence thyroid hormone levels and reduce autoimmune inflammation. Some trials in Hashimoto’s patients have reported reduced need for levothyroxine (thyroid hormone replacement) following a protocol of near-infrared light applied to the neck. These results are genuinely interesting and have attracted attention in the integrative medicine community.

Important limitation: the thyroid trials are small (typically under 50 participants), lack long-term follow-up, and have not been replicated at scale. Hashimoto’s thyroiditis is an autoimmune condition requiring medical management. RLT is not a substitute for thyroid medication, and any protocol involving the thyroid should only be undertaken with the involvement of the treating endocrinologist. This is not an application ZenGlow positions its devices for, and we do not provide thyroid-specific protocols.

The mechanistic rationale is the same as for other endocrine glands: thyroid hormone synthesis (iodination of thyroglobulin) is energy-dependent, and thyrocytes — like all cells — contain mitochondria that may benefit from PBM’s ATP-restoring effect. But plausible mechanism is not the same as confirmed clinical efficacy.

Sex Hormones: Early Research, Significant Caveats

Testosterone, estrogen, and progesterone are the primary sex hormones, produced in the gonads and regulated by the hypothalamic-pituitary-gonadal (HPG) axis. Given that steroidogenesis (sex hormone synthesis) is a mitochondria-dependent process, the theoretical basis for PBM effects is similar to other endocrine glands.

What the research shows — and does not show

The most-cited studies in this area involve animal models and in vitro research rather than human trials. Research using 810 nm near-infrared LEDs has shown effects on oxidative stress markers in reproductive tissues and improvements in sperm parameters in animal models. These findings are biologically interesting but cannot be extrapolated directly to human hormonal outcomes.

For human testosterone specifically, there is a small literature exploring the effect of PBM on the testes (via testicular irradiation), with some studies showing modest testosterone increases in male subjects. This research is preliminary and has not been reproduced in large controlled trials. The mechanism — improved mitochondrial function in Leydig cells, which produce testosterone — is plausible but unconfirmed as a clinically meaningful effect in healthy individuals.

For women’s hormonal health — menstrual regulation, estrogen balance, perimenopausal symptoms — the clinical evidence base is even thinner. Individual reports and small pilot studies exist, but nothing approaching the quality of evidence that supports, for example, RLT’s wound healing or DOMS reduction applications.

Honest position: sex hormone effects of RLT remain a research frontier. The mechanistic rationale is sound, but the human clinical evidence does not yet support specific claims about RLT improving testosterone, estrogen, or fertility outcomes. Anyone pursuing RLT for reproductive health goals should do so in consultation with a reproductive endocrinologist.

Summary: Evidence Quality by Hormonal Application

ApplicationEvidence LevelMechanism ClarityPractical Guidance
Evening melatonin (non-suppression)Strong — multiple RCTsWell-understood (ipRGC pathway)Use red light in evenings; avoid blue-enriched light pre-sleep
Morning cortisol modulationModerate — systematic review of 12 RCTsCircadian pathway (SCN entrainment)Red morning light = gentler cortisol curve vs. blue/white
HPA axis / chronic stress supportTheoretical + mechanisticPlausible via adrenal mitochondriaGeneral wellness use; not for adrenal conditions
Thyroid function (Hashimoto’s)Preliminary — small pilot studies onlyPlausible via thyrocyte ATPMedical supervision required; not a ZenGlow-positioned use
Sex hormones / reproductive healthEarly research — animal models primarilyPlausible via steroidogenesisConsult reproductive endocrinologist; insufficient human data

Using Red Light Therapy for General Hormonal Wellness

Within the bounds of what the evidence supports, here is how to use red light therapy as part of a general wellness routine with hormonal benefit in mind:

Morning session — supporting the cortisol awakening response

A 10–15 minute red/NIR session (660 nm + 850 nm) within 30–45 minutes of waking can support the cortisol awakening response without the over-stimulation risk of high-intensity blue light. This is particularly relevant for individuals who experience stress-driven morning anxiety. Position a compact ZenGlow panel or the GoldWave Mask at 20–30 cm and complete a standard 10–20 minute session while the day begins.

Evening session — melatonin-compatible recovery

A 10–15 minute session 60–90 minutes before sleep provides the skin and recovery benefits of RLT without blue-spectrum content that would suppress melatonin. Red wavelengths (630–660 nm) and NIR (810–850 nm) are safe for evening use. This session serves double duty: physical recovery from the day and a non-disruptive pre-sleep light environment. Avoid blue wavelengths (the 480 nm channel on the W7 series) in the final two hours before sleep.

Frequency and consistency

The hormonal effects of RLT — to the extent they are driven by cellular energy restoration rather than circadian signalling — are cumulative. Most users who report improvements in sleep quality, daytime energy, and mood from consistent RLT use are noting effects that develop over 4–8 weeks of daily or near-daily use. This is consistent with the general PBM literature on retrograde mitochondrial signalling and sustained gene expression changes — effects that require repeated sessions to accumulate.

ZenGlow Devices for Daily Wellness Use

For general hormonal wellness support — morning and evening sessions, skin health, and recovery — the following ZenGlow devices are appropriate:

Use CaseDeviceWhy
Daily facial + morning or evening session4 wavelength modes; no blue in Tightening/Smoothing modes for evening use. Hands-free, 70-min battery.
Upper body + face session (home)Independent per-channel control allows disabling the 480 nm blue channel for evening use. 7 wavelengths for comprehensive cellular support.
Full-body wellness session — studio or clinicFull-body coverage with independent wavelength control. Appropriate for commercial wellness operators adding RLT to a membership-based service.

Frequently Asked Questions

Does red light therapy actually raise testosterone?

The honest answer is: the evidence in humans is preliminary and the effect sizes reported in small studies are modest. The mechanistic basis (mitochondrial support of Leydig cell steroidogenesis) is plausible, but there are no large-scale RCTs confirming a clinically meaningful testosterone increase from standard RLT use in healthy adults. Anyone specifically seeking to optimise testosterone should work with a doctor and focus first on the well-evidenced interventions — sleep quality, resistance training, body composition, and stress management.

Can I use red light therapy to help with cortisol burnout or adrenal fatigue?

“Adrenal fatigue” is not a recognised medical diagnosis, but the experience of HPA axis dysregulation from chronic stress — characterised by flat cortisol curves, persistent fatigue, and poor stress resilience — is real. Red light therapy as a general cellular wellness tool may support energy recovery and sleep quality in this context, but it is not a treatment for HPA dysregulation. Addressing the root causes (sleep, chronic stressors, nutrition) is the primary intervention. RLT can be a supportive addition, not a solution.

Is it safe to use red light therapy if I have a thyroid condition?

For standard whole-body RLT sessions (chest, back, limbs), there is no known risk for individuals with common thyroid conditions including hypothyroidism or Hashimoto’s. If you are considering a protocol that specifically targets the thyroid gland with close-range NIR exposure to the neck, discuss this with your endocrinologist first — particularly if you are on thyroid medication, as the small pilot studies suggesting reduced medication need have not been replicated at scale.

Will using RLT in the evening affect my sleep?

Red and near-infrared wavelengths (630–1060 nm) do not meaningfully activate the retinal blue-light pathway that suppresses melatonin. An evening RLT session using these wavelengths is compatible with good sleep hygiene. If using a 7-wavelength panel with a 480 nm blue channel, switch that channel off for sessions within 2 hours of sleep.

How long before I notice any hormonal or sleep benefits?

The melatonin-compatible lighting effect is immediate — it operates in the session itself by not suppressing melatonin rather than by producing an acute hormonal change. Cumulative effects on sleep quality, daytime energy, and stress resilience — driven by the cellular mechanisms of consistent PBM use — are typically reported after 4–8 weeks of regular use (3–5 sessions per week). Improvements in sleep architecture are among the most commonly reported subjective benefits of consistent RLT use.

Learn More About Red Light Therapy

For the full cellular mechanism behind red light therapy’s effects, see: Red Light Therapy and the Mitochondria.For sleep-specific guidance, see: Can Red Light Improve Sleep?.

Bestsellers:
SHOPPING BAG 0
RECENTLY VIEWED 0